These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35756918)

  • 21. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of microenvironment-related genes associated with radioresistance in glioblastoma.
    Liu Y; Zhao Y; Fang J; Fang J; Yuan X
    Transl Cancer Res; 2020 Dec; 9(12):7495-7504. PubMed ID: 35117350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
    Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
    Front Genet; 2022; 13():874896. PubMed ID: 35865011
    [No Abstract]   [Full Text] [Related]  

  • 27. Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis.
    Du Z; Wang Y; Liang J; Gao S; Cai X; Yu Y; Qi Z; Li J; Xie Y; Wang Z
    Comput Struct Biotechnol J; 2022; 20():5203-5217. PubMed ID: 36187921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma.
    Ma K; Guo Q; Zhang X; Li Y
    Onco Targets Ther; 2023; 16():331-345. PubMed ID: 37274309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling.
    Zhang H; Xu Y; Deng G; Yuan F; Tan Y; Gao L; Sun Q; Qi Y; Yang K; Geng R; Jiang H; Liu B; Chen Q
    J Cancer; 2021; 12(9):2756-2767. PubMed ID: 33854635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
    Wang LJ; Lv P; Lou Y
    Front Oncol; 2022; 12():862723. PubMed ID: 35574375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
    Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
    Huang Z; Wang H; Sun D; Liu J
    Biomed Res Int; 2022; 2022():7171126. PubMed ID: 35782068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.
    Chen X; Tian F; Wu Z
    World Neurosurg; 2022 Nov; 167():e515-e526. PubMed ID: 35977679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
    Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
    Front Immunol; 2021; 12():685213. PubMed ID: 34539626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma.
    Wang F; Liu X; Jiang H; Chen B
    World Neurosurg; 2022 May; 161():e363-e375. PubMed ID: 35144031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.